Atıf Formatları
Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Baba Et Al. , "Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics," Archives of Gerontology and Geriatrics , vol.125, 2024

Baba, B. Et Al. 2024. Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics. Archives of Gerontology and Geriatrics , vol.125 .

Baba, B., Ceylani, T., GURBANOV, R., Açıkgöz, E., Keskin, S., Allahverdi, H., ... Samgane, G.(2024). Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics. Archives of Gerontology and Geriatrics , vol.125.

Baba, Burcu Et Al. "Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics," Archives of Gerontology and Geriatrics , vol.125, 2024

Baba, Burcu Et Al. "Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics." Archives of Gerontology and Geriatrics , vol.125, 2024

Baba, B. Et Al. (2024) . "Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics." Archives of Gerontology and Geriatrics , vol.125.

@article{article, author={Burcu Baba Et Al. }, title={Promoting longevity in aged liver through NLRP3 inflammasome inhibition using tauroursodeoxycholic acid (TUDCA) and SCD probiotics}, journal={Archives of Gerontology and Geriatrics}, year=2024}